Eltoukhy Helmy's Form 4 filing
Guardant Health, Inc. (GH) · filed Sep 11, 2025
- Accession no.
- 0001752968-25-000005
- Filed
- Sep 11, 2025
- Trade date
- Sep 9, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $17.8M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eltoukhy HelmyCIK 0001752968 | Director, Officer (Co-Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | Common Stock | SSaleDisposed | −294,723 | $59.44 | −$17,518,335.12 | 2,128,776 | Direct | |
| Sep 9, 2025 | Common Stock | SSaleDisposed | −5,277 | $59.93 | −$316,250.61 | 2,123,499 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.